rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Combinational therapy in triple negative breast cancer
  name:
    name part: Mir, Manzoor Ahmad.
    role:
      role term: creator
  name:
    name part: ScienceDirect (Online service)
  type of resource: text
  genre: Electronic books.
  origin info:
    place:
      place term: enk
    date issued: 2022
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource
  table of contents: Front cover -- Half title -- Copyright -- Contents -- Contributors -- About the author -- Foreword -- Preface -- Acknowledgment -- Chapter 1 -- Triple-negative breast cancer -- an aggressive subtype of breast cancer -- Introduction -- Triple-negative breast cancer (TNBC) -- TNBC histological classification -- TNBC molecular classification -- BL-1 and BL-2 -- M subtype -- MSL subtype -- IM subtype -- LAR subtype -- TNBC and BRCA -- Triple-negative breast cancer risk factors and epidemiology -- Current diagnostic options for triple-negative breast cancer -- Mammography -- Ultrasound
  table of contents: Magnetic resonance imaging (MRI) -- Future diagnostic options for TNBC -- Blood-based liquid biopsy -- Circulating tumor nucleic acids (ctNAs) -- Exosomes -- Immuno-positron emission tomography (PET) -- Nanobiosensor -- nCounter breast cancer 360 panel -- Digital polymerase chain reaction (dPCR) -- Triple-negative breast cancer's prognostic implications -- Somatic genomic mutations in TNBC -- Epigenetic modifications in TNBC -- Methylation of DNA in triple-negative breast cancer -- Relation between DNA methylation and TNBC progression -- Role of long noncoding RNAs in TNBC
  table of contents: Role of MicroRNA in TNBC -- Role of histone modifications in TNBC -- Summary -- References -- Chapter 2 -- Novel biomarkers in triple-negative breast cancer -- role and perspective -- Introduction -- Triple-negative breast cancer: Genetic markers -- TP53 -- BRCA1/2 -- PI3K pathway -- Androgen receptor -- BCL2 gene -- Cyclin-dependent kinases -- Triple-negative breast cancer: Novel biomarkers -- EGFR -- VEGF -- C-kit and basal cytokeratins -- TOP-2A -- Ki67 -- PARP -- Heat shock protein 90 -- Cox-2 -- Epigenetic modifications in TNBC as novel biomarkers -- Tissue miRNAs as biomarkers in TNBC
  note: Manzoor Mir.
  subject:
    topic: Breast
    topic: Cancer
    topic: Treatment
  subject:
    topic: Sein
    topic: Cancer
    topic: Traitement
  subject:
    topic: Breast
    topic: Cancer
    topic: Treatment
  classification: RC280.B8
  classification: 616.9944906
  related item:
    identifier: (OCoLC)1273915344
  related item:
    title info:
      title: COMBINATIONAL THERAPY IN TRIPLE NEGATIVE BREAST CANCER
    name:
      name part: MIR, MANZOOR AHMAD.
    origin info:
      publisher: [S.l.] : ELSEVIER ACADEMIC PRESS, 2022
    identifier: (OCoLC)1273915344
  identifier: 9780323961370
  identifier: 0323961371
  identifier: 9780323961363
  identifier: 0323961363
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: YDX
    record creation date: 220503
    record change date: 20260327172325.7
    record identifier: in00005769639
    language of cataloging:
      language term: eng